112 related articles for article (PubMed ID: 10558970)
1. Lack of prophylactic efficacy of an enteric-coated bovine hyperimmune milk product against enterotoxigenic Escherichia coli challenge administered during a standard meal.
Tacket CO; Losonsky G; Livio S; Edelman R; Crabb J; Freedman D
J Infect Dis; 1999 Dec; 180(6):2056-9. PubMed ID: 10558970
[TBL] [Abstract][Full Text] [Related]
2. Administration of purified colonization factor antigens (CFA/I, CFA/II) of enterotoxigenic Escherichia coli to volunteers. Response to challenge with virulent enterotoxigenic Escherichia coli.
Evans DG; Graham DY; Evans DJ
Gastroenterology; 1984 Oct; 87(4):934-40. PubMed ID: 6381216
[TBL] [Abstract][Full Text] [Related]
3. Protection by milk immunoglobulin concentrate against oral challenge with enterotoxigenic Escherichia coli.
Tacket CO; Losonsky G; Link H; Hoang Y; Guesry P; Hilpert H; Levine MM
N Engl J Med; 1988 May; 318(19):1240-3. PubMed ID: 3283555
[TBL] [Abstract][Full Text] [Related]
4. A double-blind, placebo-controlled trial to evaluate the efficacy of PTL-003, an attenuated enterotoxigenic E. coli (ETEC) vaccine strain, in protecting against challenge with virulent ETEC.
McKenzie R; Darsley M; Thomas N; Randall R; Carpenter C; Forbes E; Finucane M; Sack RB; Hall E; Bourgeois AL
Vaccine; 2008 Aug; 26(36):4731-9. PubMed ID: 18602960
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic Efficacy of Hyperimmune Bovine Colostral Antiadhesin Antibodies Against Enterotoxigenic Escherichia coli Diarrhea: A Randomized, Double-Blind, Placebo-Controlled, Phase 1 Trial.
Savarino SJ; McKenzie R; Tribble DR; Porter CK; O'Dowd A; Cantrell JA; Sincock SA; Poole ST; DeNearing B; Woods CM; Kim H; Grahek SL; Brinkley C; Crabb JH; Bourgeois AL
J Infect Dis; 2017 Jul; 216(1):7-13. PubMed ID: 28541500
[TBL] [Abstract][Full Text] [Related]
6. Oral delivery of Hyperimmune bovine serum antibodies against CS6-expressing enterotoxigenic
Talaat KR; Porter CK; Bourgeois AL; Lee TK; Duplessis CA; Maciel M; Gutierrez RL; DeNearing B; Adjoodani B; Adkinson R; Testa KJ; Feijoo B; Alcala AN; Brubaker J; Beselman A; Chakraborty S; Sack D; Halpern J; Trop S; Wu H; Jiao J; Sullivan E; Riddle MS; Joseph SS; Poole ST; Prouty MG
Gut Microbes; 2020 Nov; 12(1):1732852. PubMed ID: 32167011
[TBL] [Abstract][Full Text] [Related]
7. Construction and phase I clinical evaluation of the safety and immunogenicity of a candidate enterotoxigenic Escherichia coli vaccine strain expressing colonization factor antigen CFA/I.
Turner AK; Beavis JC; Stephens JC; Greenwood J; Gewert C; Thomas N; Deary A; Casula G; Daley A; Kelly P; Randall R; Darsley MJ
Infect Immun; 2006 Feb; 74(2):1062-71. PubMed ID: 16428753
[TBL] [Abstract][Full Text] [Related]
8. Milk immunoglobulin with specific activity against purified colonization factor antigens can protect against oral challenge with enterotoxigenic Escherichia coli.
Freedman DJ; Tacket CO; Delehanty A; Maneval DR; Nataro J; Crabb JH
J Infect Dis; 1998 Mar; 177(3):662-7. PubMed ID: 9498445
[TBL] [Abstract][Full Text] [Related]
9. Protection of neonatal calves against fatal enteric colibacillosis by administration of egg yolk powder from hens immunized with K99-piliated enterotoxigenic Escherichia coli.
Ikemori Y; Kuroki M; Peralta RC; Yokoyama H; Kodama Y
Am J Vet Res; 1992 Nov; 53(11):2005-8. PubMed ID: 1466492
[TBL] [Abstract][Full Text] [Related]
10. Mucosal and systemic immune responses in patients with diarrhea due to CS6-expressing enterotoxigenic Escherichia coli.
Qadri F; Ahmed T; Ahmed F; Bhuiyan MS; Mostofa MG; Cassels FJ; Helander A; Svennerholm AM
Infect Immun; 2007 May; 75(5):2269-74. PubMed ID: 17296752
[TBL] [Abstract][Full Text] [Related]
11. Prime-boost vaccine regimen confers protective immunity to human-derived enterotoxigenic Escherichia coli.
Lasaro MO; Luiz WB; Sbrogio-Almeida ME; Ferreira LC
Vaccine; 2005 Mar; 23(19):2430-8. PubMed ID: 15752829
[TBL] [Abstract][Full Text] [Related]
12. Analysis of efficacy of CVD 103-HgR live oral cholera vaccine against all-cause travellers' diarrhoea in a randomised, double-blind, placebo-controlled study.
Leyten EM; Soonawala D; Schultsz C; Herzog C; Ligthelm RJ; Wijnands S; Visser LG
Vaccine; 2005 Oct; 23(43):5120-6. PubMed ID: 15982790
[TBL] [Abstract][Full Text] [Related]
13. [Continuous and common epitopes present in fimbriae of enterotoxigenic Escherichia coli (ETEC)].
López-Vidal Y
Gac Med Mex; 1997; 133(6):511-25. PubMed ID: 9504082
[TBL] [Abstract][Full Text] [Related]
14. Reactogenicity, immunogenicity and efficacy studies of Escherichia coli type 1 somatic pili parenteral vaccine in man.
Levine MM; Black RE; Brinton CC; Clements ML; Fusco P; Hughes TP; O'Donnell S; Robins-Browne R; Wood S; Young CR
Scand J Infect Dis Suppl; 1982; 33():83-95. PubMed ID: 6127806
[TBL] [Abstract][Full Text] [Related]
15. Vaccines against enterotoxigenic Escherichia coli.
Svennerholm AM; Tobias J
Expert Rev Vaccines; 2008 Aug; 7(6):795-804. PubMed ID: 18665777
[TBL] [Abstract][Full Text] [Related]
16. Construction and characterization of genetically defined aro omp mutants of enterotoxigenic Escherichia coli and preliminary studies of safety and immunogenicity in humans.
Turner AK; Terry TD; Sack DA; Londoño-Arcila P; Darsley MJ
Infect Immun; 2001 Aug; 69(8):4969-79. PubMed ID: 11447175
[TBL] [Abstract][Full Text] [Related]
17. Stimulation of mucosal immune response following oral administration of enterotoxigenic Escherichia coli fimbriae (CFA/I) entrapped in liposomes in conjunction with inactivated whole-cell Vibrio cholerae vaccine.
Dima VF; Ionescu MD; Palade R; Balotescu C; Becheanu G; Dima SV
Roum Arch Microbiol Immunol; 2001; 60(1):27-54. PubMed ID: 11850896
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibodies against fimbrial subunits of colonization factor antigen I (CFA/I) inhibit binding to human enterocytes and protect against enterotoxigenic Escherichia coli expressing heterologous colonization factors.
Rudin A; Olbe L; Svennerholm AM
Microb Pathog; 1996 Jul; 21(1):35-45. PubMed ID: 8827705
[TBL] [Abstract][Full Text] [Related]
19. Bioactive Immune Components of Anti-Diarrheagenic Enterotoxigenic Escherichia coli Hyperimmune Bovine Colostrum Products.
Sears KT; Tennant SM; Reymann MK; Simon R; Konstantopoulos N; Blackwelder WC; Barry EM; Pasetti MF
Clin Vaccine Immunol; 2017 Aug; 24(8):. PubMed ID: 28637804
[TBL] [Abstract][Full Text] [Related]
20. Double-blind comparison of bismuth subsalicylate and placebo in the prevention and treatment of enterotoxigenic Escherichia coli-induced diarrhea in volunteers.
Graham DY; Estes MK; Gentry LO
Gastroenterology; 1983 Nov; 85(5):1017-22. PubMed ID: 6352386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
